KONINKLIJKE PHILIPS NV (PHIA.AS) Stock Fundamental Analysis
Europe - Euronext Amsterdam - AMS:PHIA - NL0000009538 - Common Stock
25.29 EUR
+0.4 (+1.61%)
Taking everything into account, PHIA scores 3 out of 10 in our fundamental rating. PHIA was compared to 65 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of PHIA have multiple concerns. PHIA is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
PHIA had positive earnings in the past year.
In the past year PHIA had a positive cash flow from operations.
In multiple years PHIA reported negative net income over the last 5 years.
Of the past 5 years PHIA 4 years had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 0.61%, PHIA is doing worse than 63.08% of the companies in the same industry.
With a Return On Equity value of 1.56%, PHIA is not doing good in the industry: 63.08% of the companies in the same industry are doing better.
The Return On Invested Capital of PHIA (4.27%) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.61% | ||
| ROE | 1.56% | ||
| ROIC | 4.27% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
PHIA has a Profit Margin of 0.91%. This is in the lower half of the industry: PHIA underperforms 63.08% of its industry peers.
PHIA has a Operating Margin of 6.11%. This is comparable to the rest of the industry: PHIA outperforms 43.08% of its industry peers.
PHIA's Operating Margin has declined in the last couple of years.
PHIA has a worse Gross Margin (43.85%) than 75.38% of its industry peers.
In the last couple of years the Gross Margin of PHIA has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.11% | ||
| PM (TTM) | 0.91% | ||
| GM | 43.85% |
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PHIA is destroying value.
Compared to 1 year ago, PHIA has less shares outstanding
PHIA has more shares outstanding than it did 5 years ago.
The debt/assets ratio for PHIA is higher compared to a year ago.
2.2 Solvency
PHIA has an Altman-Z score of 1.96. This is not the best score and indicates that PHIA is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.96, PHIA is doing worse than 60.00% of the companies in the same industry.
PHIA has a debt to FCF ratio of 19.41. This is a negative value and a sign of low solvency as PHIA would need 19.41 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 19.41, PHIA is in line with its industry, outperforming 41.54% of the companies in the same industry.
PHIA has a Debt/Equity ratio of 0.69. This is a neutral value indicating PHIA is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.69, PHIA is not doing good in the industry: 70.77% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 19.41 | ||
| Altman-Z | 1.96 |
ROIC/WACC0.67
WACC6.37%
2.3 Liquidity
PHIA has a Current Ratio of 1.26. This is a normal value and indicates that PHIA is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.26, PHIA is doing worse than 61.54% of the companies in the same industry.
PHIA has a Quick Ratio of 1.26. This is a bad value and indicates that PHIA is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.81, PHIA is not doing good in the industry: 67.69% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.81 |
3. Growth
3.1 Past
PHIA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.15%, which is quite good.
The Earnings Per Share has been decreasing by -7.17% on average over the past years.
The Revenue has decreased by -0.81% in the past year.
Measured over the past years, PHIA shows a small growth in Revenue. The Revenue has been growing by 1.00% on average per year.
EPS 1Y (TTM)15.15%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%12.5%
Revenue 1Y (TTM)-0.81%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-1.71%
3.2 Future
Based on estimates for the next years, PHIA will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.05% on average per year.
The Revenue is expected to grow by 3.41% on average over the next years.
EPS Next Y4.35%
EPS Next 2Y4.98%
EPS Next 3Y7.73%
EPS Next 5Y13.05%
Revenue Next Year-2.27%
Revenue Next 2Y0.25%
Revenue Next 3Y1.58%
Revenue Next 5Y3.41%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 17.09, the valuation of PHIA can be described as rather expensive.
Based on the Price/Earnings ratio, PHIA is valued cheaply inside the industry as 93.85% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.92. PHIA is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 16.57, the valuation of PHIA can be described as correct.
Based on the Price/Forward Earnings ratio, PHIA is valued a bit cheaper than the industry average as 73.85% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of PHIA to the average of the S&P500 Index (23.57), we can say PHIA is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.09 | ||
| Fwd PE | 16.57 |
4.2 Price Multiples
PHIA's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. PHIA is cheaper than 76.92% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as PHIA.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 56.11 | ||
| EV/EBITDA | 12.81 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)3.93
PEG (5Y)N/A
EPS Next 2Y4.98%
EPS Next 3Y7.73%
5. Dividend
5.1 Amount
PHIA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
AMS:PHIA (1/8/2026, 5:36:15 PM)
25.29
+0.4 (+1.61%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners44.83%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap24.35B
Revenue(TTM)18.02B
Net Income(TTM)162.00M
Analysts74.81
Price Target27.59 (9.09%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0
Dividend Growth(5Y)-70.49%
DP0.62%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)26.64%
Min EPS beat(2)22.24%
Max EPS beat(2)31.04%
EPS beat(4)2
Avg EPS beat(4)6.19%
Min EPS beat(4)-16.56%
Max EPS beat(4)31.04%
EPS beat(8)3
Avg EPS beat(8)-1.09%
EPS beat(12)5
Avg EPS beat(12)15.29%
EPS beat(16)5
Avg EPS beat(16)3.51%
Revenue beat(2)0
Avg Revenue beat(2)-1.96%
Min Revenue beat(2)-1.97%
Max Revenue beat(2)-1.96%
Revenue beat(4)0
Avg Revenue beat(4)-3.05%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)-1.96%
Revenue beat(8)0
Avg Revenue beat(8)-3.22%
Revenue beat(12)2
Avg Revenue beat(12)-1.61%
Revenue beat(16)2
Avg Revenue beat(16)-1.84%
PT rev (1m)-0.21%
PT rev (3m)0.65%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.38%
EPS NY rev (1m)0.43%
EPS NY rev (3m)3.91%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.41%
Revenue NY rev (1m)-0.4%
Revenue NY rev (3m)-0.62%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.09 | ||
| Fwd PE | 16.57 | ||
| P/S | 1.36 | ||
| P/FCF | 56.11 | ||
| P/OCF | 22.16 | ||
| P/B | 2.35 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.81 |
EPS(TTM)1.48
EY5.85%
EPS(NY)1.53
Fwd EY6.04%
FCF(TTM)0.45
FCFY1.78%
OCF(TTM)1.14
OCFY4.51%
SpS18.54
BVpS10.78
TBVpS-1.76
PEG (NY)3.93
PEG (5Y)N/A
Graham Number18.95
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.61% | ||
| ROE | 1.56% | ||
| ROCE | 5.69% | ||
| ROIC | 4.27% | ||
| ROICexc | 4.72% | ||
| ROICexgc | 15.5% | ||
| OM | 6.11% | ||
| PM (TTM) | 0.91% | ||
| GM | 43.85% | ||
| FCFM | 2.43% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y10.6%
ROICexgc growth 5Y-2.51%
ROICexc growth 3Y4.73%
ROICexc growth 5Y-6.98%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
F-Score8
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 19.41 | ||
| Debt/EBITDA | 3.01 | ||
| Cap/Depr | 51.35% | ||
| Cap/Sales | 3.72% | ||
| Interest Coverage | 4 | ||
| Cash Conversion | 46.06% | ||
| Profit Quality | 267.9% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.81 | ||
| Altman-Z | 1.96 |
F-Score8
WACC6.37%
ROIC/WACC0.67
Cap/Depr(3y)50.01%
Cap/Depr(5y)53.78%
Cap/Sales(3y)3.94%
Cap/Sales(5y)4.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.15%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%12.5%
EPS Next Y4.35%
EPS Next 2Y4.98%
EPS Next 3Y7.73%
EPS Next 5Y13.05%
Revenue 1Y (TTM)-0.81%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-1.71%
Revenue Next Year-2.27%
Revenue Next 2Y0.25%
Revenue Next 3Y1.58%
Revenue Next 5Y3.41%
EBIT growth 1Y476.21%
EBIT growth 3Y0.03%
EBIT growth 5Y-7.17%
EBIT Next Year48.95%
EBIT Next 3Y19.49%
EBIT Next 5YN/A
FCF growth 1Y3516.67%
FCF growth 3Y-40.93%
FCF growth 5Y-1.73%
OCF growth 1Y43.47%
OCF growth 3Y-32.38%
OCF growth 5Y-4.03%
KONINKLIJKE PHILIPS NV / PHIA.AS FAQ
Can you provide the ChartMill fundamental rating for KONINKLIJKE PHILIPS NV?
ChartMill assigns a fundamental rating of 3 / 10 to PHIA.AS.
What is the valuation status of KONINKLIJKE PHILIPS NV (PHIA.AS) stock?
ChartMill assigns a valuation rating of 4 / 10 to KONINKLIJKE PHILIPS NV (PHIA.AS). This can be considered as Fairly Valued.
Can you provide the profitability details for KONINKLIJKE PHILIPS NV?
KONINKLIJKE PHILIPS NV (PHIA.AS) has a profitability rating of 2 / 10.
How financially healthy is KONINKLIJKE PHILIPS NV?
The financial health rating of KONINKLIJKE PHILIPS NV (PHIA.AS) is 2 / 10.
Can you provide the dividend sustainability for PHIA stock?
The dividend rating of KONINKLIJKE PHILIPS NV (PHIA.AS) is 0 / 10 and the dividend payout ratio is 0.62%.